In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...

MindRank AI Ltd. (“MindRank”), a clinical-stage biotechnology company dedicated to building an AI-native engine for drug research and development, today announced the completion of a $52 million ...

Nitrenes are the ghosts of synthetic chemistry, formed in an instant and gone just as quickly, rearranging into something ...

Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...

Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.

Structural complexity in modern small molecules is reshaping what drug development partners must deliver from discovery through commercial supply.Targeted protein degraders, covalent agents, and a new ...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational biology and chemistry company leveraging artificial intelligence (AI) to discover and develop innovative small-molecule products for the ...

A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.

Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) ...

SHANGHAI and GUANGZHOU, China, July 4, 2026 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. ("Sanyou Bio") and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. ("Baiyunshan Xihe") jointly ...

Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing ...

Brown University chemists have provided direct evidence that upends the textbook explanation of how triple chemical bonds ...